Toronto Dominion Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1M Sell
448,198
-575,853
-56% -$46.1M 0.04% 336
2025
Q4
$97.6M Buy
1,024,051
+470,096
+85% +$46.1M 0.14% 142
2025
Q3
$54.1M Sell
553,955
-52,079
-9% -$5.39M 0.08% 223
2025
Q2
$65.1M Sell
606,034
-280,406
-32% -$28.4M 0.11% 163
2025
Q1
$89.4M Buy
886,440
+89,491
+11% +$9.01M 0.18% 105
2024
Q4
$71.2M Buy
796,949
+54,022
+7% +$4.76M 0.11% 132
2024
Q3
$62.3M Sell
742,927
-85,171
-10% -$6.71M 0.11% 132
2024
Q2
$63.8M Buy
828,098
+77,006
+10% +$5.64M 0.1% 121
2024
Q1
$51.4M Sell
751,092
-94,729
-11% -$6.09M 0.08% 162
2023
Q4
$48.9M Sell
845,821
-226,903
-21% -$12.1M 0.07% 197
2023
Q3
$56.6M Sell
1,072,724
-145,593
-12% -$7.64M 0.09% 168
2023
Q2
$65.9M Sell
1,218,317
-17,059
-1% -$891K 0.1% 161
2023
Q1
$61.8M Buy
1,235,376
+63,601
+5% +$3M 0.1% 154
2022
Q4
$54.2M Sell
1,171,775
-229,661
-16% -$9.94M 0.08% 174
2022
Q3
$54.3M Sell
1,401,436
-188,905
-12% -$7.58M 0.1% 144
2022
Q2
$59.3M Sell
1,590,341
-44,632
-3% -$1.82M 0.11% 128
2022
Q1
$72.4M Buy
1,634,973
+766,610
+88% +$33.2M 0.11% 126
2021
Q4
$36.9M Sell
868,363
-421,886
-33% -$17.7M 0.05% 222
2021
Q3
$56M Buy
1,290,249
+166,530
+15% +$7.37M 0.09% 137
2021
Q2
$48M Sell
1,123,719
-73,428
-6% -$3.09M 0.07% 166
2021
Q1
$46.3M Buy
1,197,147
+119,285
+11% +$4.51M 0.08% 157
2020
Q4
$38.7M Buy
1,077,862
+230,165
+27% +$8.3M 0.07% 174
2020
Q3
$32.4M Sell
847,697
-115,158
-12% -$4.44M 0.08% 160
2020
Q2
$33.8M Sell
962,855
-117,340
-11% -$4.23M 0.09% 158
2020
Q1
$35.3M Sell
1,080,195
-243,681
-18% -$9.52M 0.11% 143
2019
Q4
$59.9M Buy
1,323,876
+271,329
+26% +$11.4M 0.1% 140
2019
Q3
$42.8M Sell
1,052,547
-915,929
-47% -$38.8M 0.09% 158
2019
Q2
$42.3M Buy
1,968,476
+976,891
+99% +$37.6M 0.09% 157
2019
Q1
$38M Buy
991,585
+147,823
+18% +$5.65M 0.06% 179
2018
Q4
$29.8M Sell
843,762
-73,150
-8% -$2.65M 0.05% 175
2018
Q3
$35.3M Buy
916,912
+27,288
+3% +$953K 0.06% 178
2018
Q2
$29.1M Buy
889,624
+148,595
+20% +$4.48M 0.06% 211
2018
Q1
$20.2M Buy
741,029
+149,579
+25% +$4.07M 0.05% 236
2017
Q4
$14.7M Buy
591,450
+71,085
+14% +$1.96M 0.04% 261
2017
Q3
$15.2M Buy
520,365
+56,539
+12% +$1.56M 0.05% 211
2017
Q2
$12.9M Buy
463,826
+95,902
+26% +$2.55M 0.04% 228
2017
Q1
$9.15M Buy
367,924
+133,121
+57% +$3.24M 0.02% 258
2016
Q4
$5.08M Buy
234,803
+195,094
+491% +$4.26M 0.02% 301
2016
Q3
$945K Buy
39,709
+32,297
+436% +$770K ﹤0.01% 441
2016
Q2
$173K Sell
7,412
-2,922
-28% -$63.2K ﹤0.01% 602
2016
Q1
$194K Sell
10,334
-30,901
-75% -$543K ﹤0.01% 562
2015
Q4
$760K Sell
41,235
-1,557
-4% -$27.9K ﹤0.01% 411
2015
Q3
$702K Buy
42,792
+5,802
+16% +$99.2K ﹤0.01% 411
2015
Q2
$655K Buy
36,990
+394
+1% +$7.04K ﹤0.01% 466
2015
Q1
$650K Sell
36,596
-18,134
-33% -$287K ﹤0.01% 459
2014
Q4
$725K Buy
54,730
+29,705
+119% +$380K ﹤0.01% 483
2014
Q3
$296K Buy
25,025
+69
+0.3% +$869 ﹤0.01% 535
2014
Q2
$319K Buy
24,956
+3,814
+18% +$49.6K ﹤0.01% 607
2014
Q1
$286K Sell
21,142
-169
-0.8% -$2.22K ﹤0.01% 605
2013
Q4
$256K Buy
+21,311
New +$252K ﹤0.01% 605

Other funds holding BSX

Toronto Dominion Bank's BSX Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Boston Scientific (BSX) stake by 56% in Q1 2026, selling an estimated $46.1M and leaving 448,198 shares worth $28.1M. The position accounts for 0.04% of the portfolio, ranked #336.

Toronto Dominion Bank first reported a position in BSX in Q4 2013 and has held it in 50 quarters since. The position peaked at $97.6M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Toronto Dominion Bank held 448,198 shares of Boston Scientific worth $28.1M as of Q1 2026.
  • Toronto Dominion Bank sold 575,853 Boston Scientific shares in Q1 2026, an estimated $46.1M.
  • Boston Scientific made up 0.04% of Toronto Dominion Bank's portfolio in Q1 2026, its #336 holding.
  • Toronto Dominion Bank first reported a position in Boston Scientific in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Boston Scientific position peaked at $97.6M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.